Yantacaw Capital
Venture fund · from SEC filings

New Leaf Biopharma Opportunities I, L.P.

New Leaf Venture Partners · adviser of record: New Leaf Venture Partners LLC · 2013 vintage

New Leaf Biopharma Opportunities I, L.P. is a 2013 venture fund managed by New Leaf Venture Partners, with $200mm raised (Form D, amount sold). It reported $10mm in gross assets at year-end 2023, 0.05x its size, against a peak of $204mm in 2017.

Latest value held
$10mm year-end 2023
Peak
$204mm year-end 2017
Fund size
$200mm Form D, amount sold
Held vs. size
0.05x peak 1.02x

Value held by year-end

$50mm$100mm$150mm$200mm$250mm20132014201520162017201820192020202120222023

Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker

Year-endGross assets÷ sizeChange
2023$10mm0.05x-77%
2022$44mm0.22x+27%
2021$34.6mm0.17x-48%
2020$66.7mm0.33x-50%
2019$133mm0.66x-21%
2018$169mm0.85x-17%
2017$204mm1.02x+43%
2016$142mm0.71x+17%
2015$121mm0.61x–
2014$0k0.00x–
2013$0k0.00x–

Other funds from New Leaf Venture Partners

All New Leaf Venture Partners funds

About these numbers

Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-4788944911. Data updated October 13, 2026.

Is this your fund?

Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.